Current Opinion in Oncology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of psychiatry is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Martine J. Piccart, MD, PhD, is Professor of Oncology at the Université Libre de Bruxelles (ULB) and Director of the Medicine Department at the Institut Jules Bordet, in Brussels, Belgium.
Dr Piccart earned her MD and PhD at the Université Libre de Bruxelles, Belgium, and received her oncology qualifications in New York and London. She is a member of the “Académie Royale de Médecine de Belgique”.
With a primary interest in breast cancer and drug development, Dr Piccart has a genuine interest for international research collaborations, and is the principal or co-principal investigator of many clinical trials, including HERA, MINDACT, and ALTTO. She is co-founder and chair of the Brussels-based Breast International Group (BIG), created in 1996 to facilitate international breast cancer clinical trials, and TRANSBIG, a European Commission supported translational research consortium to complement BIG's clinical research network. BIG brings together 41 collaborative groups from around the world and has over 30 trials under its umbrella. TRANSBIG represents 39 institutions in 21 countries.
Dr Piccart is an active member of many professional organizations, currently serving on the American Society of Clinical Oncology (ASCO) Board and as president of the European Organization for the Research and Treatment of Cancer (EORTC). She is author or co-author of more than 300 scientific publications in peer-reviewed journals and has received numerous prestigious awards for her contribution to research in oncology, including the ESMO Award for Exceptional Contribution to the Advancement of Medical Oncology in Europe (1997), a “Jacqueline Seroussi Memorial Foundation for Cancer Research Award” for “International leadership in translational and clinical research that has improved treatment outcomes for women with early stage and advanced breast cancer” (2005), the 14th Claude Jacquillat Award for achievements in clinical oncology (2006) and the ESMO-GSK Lifetime Achievement Award in Breast Cancer Research (to the Breast International Group in 2006). She was awarded the “Miami Breast Cancer Conference Award of Excellence for 2007”, at the Miami Breast Cancer Conference in February 2007 and will receive the Jill Rose Award for distinguished biomedical research at the 2009 BCRF Symposium in New-York.
Steven T. Rosen
Steven Rosen, MD, FACP, is Genevieve Teuton Professor of Medicine at the Feinberg School of Medicine, Northwestern University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Director of Cancer Programs at Northwestern Memorial Hospital. Following his graduation with distinction from Northwestern University Medical School's Six-Year Honors Program in 1976, Dr Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr Rosen's laboratory research focuses on experimental therapeutics and hematologic malignancies. Dr Rosen has received numerous grants awards and contracts and has published more than 200 scientific papers. As Director of the Cancer Center, Dr Rosen has successfully competed for an NCI Cancer Center Support Grant, NCI grants for his laboratory research, an NCI RAID Contract grant for the development of a novel purine analog, and grants from the Leukemia and Lymphoma Society of America and the American Cancer Society.
Dr Rosen serves on several editorial boards and is editor of Cancer Treatment & Research and Oncology News International. He is a member of all major national associations that focus on oncology and has held leadership positions in the Eastern Cooperative Oncology Group, the American Association of Cancer Institutes and the National Comprehensive Cancer Network. He serves on the advisory boards of several NCI-designated Cancer Centers, the Leukemia and Lymphoma Society of America, the Multiple Myeloma Research Foundation, the Lymphoma Research Foundation and the Wendy Will Cancer Research Foundation. He has also served as an advisor to the UK's Cancer Research Campaign. Dr Rosen was the recipient of Northwestern University Medical School's Alumni Achievement Award (1994), the Martin Luther King Humanitarian Award from Northwestern Memorial Hospital (1995), the Marv Samuel Award from the Chicago Baseball Cancer Charities (1996) and recognition from the Women's Board of Northwestern Memorial Hospital for Compassionate Care (1996). He is acknowledged in Best Doctors and Oncologists in America, and Best Doctors in Chicago.
Marc Sanson, MD, PhD is Professor at P&M Curie University, Department of Neurology and Neuro-oncology, Pitié-Salpêtrière Hospital, in Paris, France.
Dr Sanson has published numerous research articles on neuro-oncology, including more than 100 papers dedicated to gliomas, as well as book chapters, and is a frequently requested lecturer on this topic. His main interest is focused on clinical and translational research on gliomas, including novel therapies, genetic alterations and new biomarkers.
He is a reviewer on a number of journals, including the Journal of Clinical Oncology, Lancet, Annals of Neurology, Neurology, Cancer, Clinical Cancer Research, and Cancer Research.
Dr Sanson earned his MD at University R Descartes and his PhD at University D Diderot, both in Paris. He completed a residency in Neurology in Paris, and a post-doc at McGill University, Canada.
Miguel A. Sanz
Miguel Sanz is Head at the Department of Hematology and Bone Marrow Transplant Unit at the University Hospital La Fe in Valencia, Spain, as well as Associate Professor of Medicine at the University of Valencia. After earning his medical degree at the University of Salamanca in Spain, he was intern, resident and subsequently completed a fellowship in Hematology at the University Hospital La Fe. Professor Sanz is Chairman of the Spanish PETHEMA Group and of the Working Parties of Acute Promyelocytic Leukemia, Acute Myeloid Leukemia and Infections in Neutropenic Patients. He is currently a reviewer for numerous high-profile medical journals, and has authored more than 400 papers, 80 book chapters, and in excess of 950 abstracts at national and international meetings.